BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22335271)

  • 1. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
    Zhu J; He J; Liu Y; Simeone DM; Lubman DM
    J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
    Zhu J; Nie S; Wu J; Lubman DM
    J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
    Huang P; Wang CY; Gou SM; Wu HS; Liu T; Xiong JX
    World J Gastroenterol; 2008 Jun; 14(24):3903-7. PubMed ID: 18609717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas.
    Oliveira-Costa JP; Zanetti JS; Silveira GG; Soave DF; Oliveira LR; Zorgetto VA; Soares FA; Zucoloto S; Ribeiro-Silva A
    Diagn Pathol; 2011 Aug; 6():73. PubMed ID: 21824412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
    Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms.
    Soave DF; Oliveira da Costa JP; da Silveira GG; Ianez RC; de Oliveira LR; Lourenço SV; Ribeiro-Silva A
    Diagn Pathol; 2013 Feb; 8():29. PubMed ID: 23419168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.
    Roudi R; Madjd Z; Ebrahimi M; Samani FS; Samadikuchaksaraei A
    Cell Mol Biol Lett; 2014 Mar; 19(1):23-36. PubMed ID: 24363164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
    Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
    Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell-related markers in primary breast cancers and associated metastatic lesions.
    Guler G; Balci S; Costinean S; Ussakli CH; Irkkan C; Suren D; Sari E; Altundag K; Ozisik Y; Jones S; Bacher J; Shapiro CL; Huebner K
    Mod Pathol; 2012 Jul; 25(7):949-55. PubMed ID: 22388757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44+/CD24+-Expressing Cervical Cancer Cells and Radioresistant Cervical Cancer Cells Exhibit Cancer Stem Cell Characteristics.
    Zhang J; Chen X; Bian L; Wang Y; Liu H
    Gynecol Obstet Invest; 2019; 84(2):174-182. PubMed ID: 30317240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pancreatic cancer stem cells.
    Li C; Heidt DG; Dalerba P; Burant CF; Zhang L; Adsay V; Wicha M; Clarke MF; Simeone DM
    Cancer Res; 2007 Feb; 67(3):1030-7. PubMed ID: 17283135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling.
    Tyagi N; Marimuthu S; Bhardwaj A; Deshmukh SK; Srivastava SK; Singh AP; McClellan S; Carter JE; Singh S
    Cancer Lett; 2016 Jan; 370(2):260-7. PubMed ID: 26546043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
    Han SA; Jang JH; Won KY; Lim SJ; Song JY
    Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach.
    He J; Liu Y; Xie X; Zhu T; Soules M; DiMeco F; Vescovi AL; Fan X; Lubman DM
    J Proteome Res; 2010 May; 9(5):2565-72. PubMed ID: 20235609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors.
    Salaria S; Means A; Revetta F; Idrees K; Liu E; Shi C
    Am J Clin Pathol; 2015 Oct; 144(4):642-8. PubMed ID: 26386086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells.
    Oonishi K; Cui X; Hirakawa H; Fujimori A; Kamijo T; Yamada S; Yokosuka O; Kamada T
    Radiother Oncol; 2012 Nov; 105(2):258-65. PubMed ID: 23017870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
    Ohara Y; Oda T; Sugano M; Hashimoto S; Enomoto T; Yamada K; Akashi Y; Miyamoto R; Kobayashi A; Fukunaga K; Morishita Y; Ohkohchi N
    Cancer Sci; 2013 Aug; 104(8):1127-34. PubMed ID: 23679813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.